{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:36Z","timestamp":1762876116566,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":1006,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005362","name":"Universita degli Studi di Bari Aldo Moro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/jth.14656","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T02:28:10Z","timestamp":1569896890000},"page":"381-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A"],"prefix":"10.1016","volume":"18","author":[{"given":"Fabrizio","family":"Semeraro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta T.","family":"Ammollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavinia","family":"Dirienzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Vitulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Santagostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-8095","authenticated-orcid":false,"given":"Mario","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14656_bb0010","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias \u2010 from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14656_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","article-title":"A longitudinal study of orthopaedic outcomes for severe factor\u2010VIII\u2010deficient haemophiliacs. The orthopaedic outcome study group","volume":"236","author":"Aledort","year":"1994","journal-title":"J Intern Med"},{"key":"10.1111\/jth.14656_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2516.2000.00397.x","article-title":"The orthopaedic status of severe haemophiliacs in Spain","volume":"6","author":"Aznar","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/MBC.0b013e3283614210","article-title":"Factors that influence the bleeding phenotype in severe hemophilic patients","volume":"24","author":"Rendo","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14656_bb0030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1538-7836.2011.04358.x","article-title":"Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A","volume":"9","author":"Ninivaggi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2516.2004.01036.x","article-title":"A 6\u2010year follow\u2010up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia","volume":"10","author":"Ahnstrom","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/hae.12438","article-title":"Considerations in individualizing prophylaxis in patients with haemophilia A","volume":"20","author":"Valentino","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Dargaud","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2516.2005.01107.x","article-title":"Thrombin generation and phenotypic correlation in haemophilia A","volume":"11","author":"Beltran\u2010Miranda","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1538-7836.2010.03767.x","article-title":"Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile","volume":"8","author":"Santagostino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0060","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.thromres.2013.04.004","article-title":"Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics","volume":"131","author":"Tarandovskiy","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14656_bb0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2141.2008.07063.x","article-title":"Thromboelastography in children with coagulation factor deficiencies","volume":"142","author":"Chitlur","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14656_bb0070","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00062752-199603050-00010","article-title":"Thrombin\u2010dependent inhibition of fibrinolysis","volume":"3","author":"Broze","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.14656_bb0075","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.ATV.20.12.2511","article-title":"Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway","volume":"20","author":"Bajzar","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14656_bb0080","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V88.10.3815.bloodjournal88103815","article-title":"Coagulation\u2010dependent inhibition of fibrinolysis: role of carboxypeptidase\u2010U and the premature lysis of clots from hemophilic plasma","volume":"88","author":"Broze","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.14656_bb0085","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2011-11-392308","article-title":"Solulin increases clot stability in whole blood from humans and dogs with hemophilia","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.14656_bb0090","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2018-01-828434","article-title":"Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding","volume":"132","author":"Wyseure","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.14656_bb0095","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1111\/j.1365-2516.2011.02648.x","article-title":"Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A","volume":"18","author":"Foley","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0100","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jth.13342","article-title":"Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin\u2010independent impairment of the thrombin\u2010activatable fibrinolysis inhibitor pathway","volume":"14","author":"Colucci","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0105","first-page":"3","article-title":"Prophylaxis: musculoskeletal evaluation","volume":"30","author":"Gilbert","year":"1993","journal-title":"Semin Hematol"},{"key":"10.1111\/jth.14656_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00003086-198006000-00018","article-title":"A radiologic classification of hemophilic arthropathy","volume":"149","author":"Pettersson","year":"1980","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/jth.14656_bb0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2010.03739.x","article-title":"Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin\u2010activatable fibrinolysis inhibitor","volume":"8","author":"Ammollo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0120","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/jth.12431","article-title":"Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin\u2010activatable fibrinolysis inhibitor but not the anti\u2010inflammatory activity on osteopontin and C5a","volume":"11","author":"Semeraro","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0125","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood-2003-06-2169","article-title":"Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI\u2010mediated mechanism","volume":"103","author":"Colucci","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.14656_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjh.14255","article-title":"Bleeding related to disturbed fibrinolysis","volume":"175","author":"Kolev","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14656_bb0135","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1046\/j.1538-7836.2003.00444.x","article-title":"Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A","volume":"1","author":"Lisman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0037-1616530","article-title":"The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.thromres.2011.10.031","article-title":"Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation","volume":"129","author":"Colucci","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14656_bb0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0037-1615650","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t\u2010PA","volume":"85","author":"Colucci","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1538-7836.2004.00605.x","article-title":"Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold dependent mechanism","volume":"2","author":"Leurs","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0160","doi-asserted-by":"crossref","first-page":"27896","DOI":"10.1074\/jbc.M401027200","article-title":"The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin\u2010activable fibrinolysis inhibitor is masked by its instability","volume":"279","author":"Walker","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14656_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2015.12.023","article-title":"Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation","volume":"138","author":"Semeraro","year":"2016","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14656_bb0170","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1046\/j.1538-7836.2003.00329.x","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)","volume":"1","author":"Bouma","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/00365510410003093","article-title":"Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?","volume":"64","author":"Antovic","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/jth.14656_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/jth.12102","article-title":"Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI\u2010mediated inhibition of fibrinolysis","volume":"11","author":"Incampo","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1538-7836.2009.03311.x","article-title":"Functional analysis of mutant variants of thrombin activatable fibrinolysis inhibitor resistant to activation by thrombin or plasmin","volume":"7","author":"Miah","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0190","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1182\/blood-2007-03-078824","article-title":"Thrombin\u2013thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon","volume":"110","author":"Binette","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.14656_bb0195","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2516.2002.00686.x","article-title":"Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia","volume":"8","author":"Grunewald","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2516.2001.00571.x","article-title":"Total thrombin\u2010activatable fibrinolysis inhibitor (TAFI) antigen and pro\u2010TAFI in patients with haemophilia A","volume":"7","author":"Antovic","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14656_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.11.008","article-title":"Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A","volume":"173","author":"Mikovic","year":"2019","journal-title":"Thromb Res"},{"issue":"Suppl. 1","key":"10.1111\/jth.14656_bb0210","first-page":"PB170","article-title":"A novel fluorescent assay for the measurement of activated thrombin\u2010activatable fibrinolysis inhibitor (TAFIa) activity","volume":"1","author":"Marar","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"19","key":"10.1111\/jth.14656_bb0215","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1182\/blood-2012-11-469403","article-title":"Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A","volume":"121","author":"Carcao","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14656_bb0220","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1111\/jth.14656_bb0225","first-page":"PB1970","article-title":"FVIII\u2010vWF complex displays greater efficiency than vWF\u2010free preparations in restoring thrombin generation in hemophilic plasma with inhibitor under conditions of physiological relevance","volume":"1","author":"Ammollo","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14656_bb0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1751-553X.2011.01349.x","article-title":"On\u2010demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients","volume":"34","author":"Mikovic","year":"2012","journal-title":"Int J Lab Hematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14656","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622014957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622014957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:27:04Z","timestamp":1761535624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622014957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1538783622014957"],"URL":"https:\/\/doi.org\/10.1111\/jth.14656","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}